B-RAF with PLX4032
From Proteopedia
(Difference between revisions)
| Line 4: | Line 4: | ||
| - | <applet load='3og7' size=' | + | <applet load='3og7' size='800' color='white' frame='true' align='right' caption='testcaption' /> |
<scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene><br> | <scene name='B-RAF_with_PLX4032/Plx_4032_only/1'>PLX 4032</scene><br> | ||
<scene name='B-RAF_with_PLX4032/Atp/1'>ATP</scene><br> | <scene name='B-RAF_with_PLX4032/Atp/1'>ATP</scene><br> | ||
Revision as of 18:14, 7 October 2010
B-RAF with PLX4032
PLX4032 is a newly synthesized drug that is being used to treat malignant melanoma with a specific mutation. The mutation is B-RAF^(V600E). This drug is highly selective for this mutation and will not bind to wild type B-RAF.
|
